about
Toxigenic clostridiaClostridium difficile: its disease and toxinsHigh temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display systemReactive arthritis induced by Clostridium difficile.Effect of clindamycin and lincomycin therapy on faecal flora.Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases.Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine.Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial.Morphology of experimental antibiotic-associated enterocolitis in the hamster: a model for human pseudomembranous colitis and antibiotic-associated diarrhoea.Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitisAn epidemic of pseudomembranous colitis: importance of person to person spread.Clostridium difficile in association with sporadic diarrhoea.Treatment of Clostridium difficile-associated diarrhea.Pseudomembranous colitis: isolation of two species of cytotoxic clostridia and successful treatment with vancomycin.Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.Bacillus pumilus in the induction of clindamycin-associated enterocolitis in guinea pigsClostridium difficile: clinical disease and diagnosisClostridium difficile isolated from the stool of a patient with pseudomembranous colits following ampicillin plus flucloxacillin (Magnapen) therapy.Clinical importance and representation of toxigenic and non-toxigenic Clostridium difficile cultivated from stool samples of hospitalized patients.Recent developments on the role of Clostridium difficile in inflammatory bowel diseaseClostridium difficile toxin as a confounding factor in enterovirus isolation.Clostridium difficile infection and inflammatory bowel disease.Variations in virulence and molecular biology among emerging strains of Clostridium difficile.An overview of the diagnosis and management of Clostridium difficile infection.The impact of Clostridium difficile on paediatric surgical practice: a systematic review.Update on pseudomembranous colitis.Rapid detection and presumptive identification of Clostridium difficile by p-cresol production on a selective medium.Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective.Clostridium difficile and cytotoxin in routine faecal specimens.Clostridium difficile induced colitis occurring during cefotaxime therapy.Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.Rapid detection of Clostridium difficile toxin in human feces.Medical management of antimicrobial-associated diarrhea and colitis.Purification and characterization of Clostridium difficile toxin.Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients.Clindamycin-associated enterocolitis in guinea pigs: evidence for a bacterial toxin.A micro-method for detecting toxins in pseudomembranous colitisLight and electron microscopic studies of antibiotic associated colitis in the hamster.Spectrum of antibiotic-associated diarrhoea.
P2860
Q24616838-F0F1CC96-A4C7-4AB1-BCDD-ECAEAB1D0ADCQ24617347-9C42A5D2-B855-4878-82D1-3F6BCA4E6776Q30300865-15FE53A7-EC59-4523-B38E-DE665E942947Q30782773-F5FCD40D-F8B3-4F1C-BB38-5B5DA3CA35D0Q33607469-5D9F4124-2A07-4F1D-8431-59EA2B6DD544Q33846331-274C73D7-2A93-4FD0-8BE1-EA1C97C4FD27Q33847707-2ADC8914-B9D9-4000-BB5D-16E33E90FBC0Q34157048-47C19A16-89B9-4AB1-8FBE-06E75132BB78Q34249194-EDBED9EB-003E-4DF2-A59E-39DDB20D9954Q34475487-879D8912-D405-4CB0-B0AC-65EBA57EF54EQ34494963-7768439F-6204-469A-A4BF-6830826D4910Q34530307-FEAF4E23-EA62-4382-9D98-C09CD219B198Q34747182-BB2F60F4-01EE-46E8-A8D2-9463BA1E6AF5Q34979678-7AEC3F08-95D2-4B34-AA61-A8080468C1B3Q35674248-C5C6B2A0-3E2B-4FC9-B0A8-CCA9C17361F1Q35756272-38327728-6C5E-4791-A54E-2D3E1CCC3F4DQ36434287-DC85B7F1-96E0-4BDF-BDEE-557F081266B9Q36640296-7FB13E69-BCAC-49E0-BCE3-BC8C61A96421Q36716484-DF1DECE6-D99C-41DC-9715-03414A2E10C4Q37160199-6B87EB98-8A9A-4609-903E-287F59B94249Q37261892-0099B269-57EA-4DD4-9573-C0A3FBAD1CF1Q37331161-5B8FB2CD-0CC3-4B1C-943B-078380ABB0E3Q37660401-C46963C4-BFEB-4D36-AEE9-CBB8B37C83F4Q37680481-626197C9-C754-42B3-AC64-F5AE9D84CB91Q37992487-130EC622-36D9-4F06-A567-A30F30F71D95Q38227743-4FB6C781-BBEB-40D1-9FA0-BD5B447D8339Q38762168-D724312A-2393-45A9-A1A5-E58DE5D0ED80Q39349058-BD783B34-06AB-42B5-96B6-E0832E99D2CEQ39434431-87E18C0A-B4FF-46D7-8671-E84BCA0990DCQ39490471-AD6279CF-B9F6-4DF2-8789-A6C9592F3A2CQ39792102-2C1A5913-C32A-494D-8B56-DE30EBA521E9Q40229451-28BF86D7-A839-4AF3-883C-4B25076C3D37Q40231483-95D9E8A6-6B76-427E-B401-0058E75BEA75Q40256149-5238E3DA-9C76-424A-BD37-B93130F4E413Q40877544-16BD1B10-254E-482D-99BE-1FF483D3C9E0Q40910705-A2E22231-2B09-4A05-A556-E72D44679F8BQ41150825-648B5D61-D1FE-40C0-8CD3-89699F560184Q41501055-C0A5B5D4-CC5B-478C-A23A-FAD88AD0D2A9Q43255149-73C15A1B-B67D-49BF-9FE4-85E35B9C0AF6Q43255445-0BE504AE-7D01-4E50-958D-A510BBAD74DE
P2860
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh-hant
name
Undescribed toxin in pseudomembranous colitis.
@en
Undescribed toxin in pseudomembranous colitis.
@nl
type
label
Undescribed toxin in pseudomembranous colitis.
@en
Undescribed toxin in pseudomembranous colitis.
@nl
prefLabel
Undescribed toxin in pseudomembranous colitis.
@en
Undescribed toxin in pseudomembranous colitis.
@nl
P2093
P2860
P356
P1433
P1476
Undescribed toxin in pseudomembranous colitis.
@en
P2093
P2860
P304
P356
10.1136/BMJ.1.6071.1246
P407
P577
1977-05-01T00:00:00Z